![](/images/graphics-bg.png)
Statin Improves Flow-Mediated Vasodilation in Chronic Kidney Diseases
المؤلفون المشاركون
Suzuki, Hiromichi
Takenaka, Tsuneo
Watanabe, Yusuke
Takane, Hiroshi
Kikuta, Tomohiro
المصدر
International Journal of Hypertension
العدد
المجلد 2013، العدد 2013 (31 ديسمبر/كانون الأول 2013)، ص ص. 1-9، 9ص.
الناشر
Hindawi Publishing Corporation
تاريخ النشر
2013-12-11
دولة النشر
مصر
عدد الصفحات
9
التخصصات الرئيسية
الملخص EN
Background.
Numbers of drugs are required to manage patients with chronic kidney disease (CKD).
Drug adherence is relatively poor in this population.
Methods.
In 36 CKD patients with hypertension and dyslipidemia, who were prescribing amlodipine 5 mg and atorvastatin 10 mg daily, the influences of exchanging to a combination drug containing equivalent doses of amlodipine and atorvastatin were observed for 6 months.
Results.
At the baseline, flow-mediated dilation (FMD) was reduced (2.4 ± 0.3%), and proteinuria was significantly contributed to decrements of FMD (R2=0.38, F=3.7, df (6,29), and P<0.01).
Six months later from exchanging to combination drug, total cholesterol (TC, 197 ± 5 to 183 ± 3 mg/dL, P<0.01) and triglycerides (142 ± 14 to 129 ± 10 mg/dL, P<0.05) were decreased, but high density lipoprotein cholesterol (53 ± 3 to 56 ± 3 mg/dL, P<0.05) was increased.
FMD was slightly albeit significantly improved to 2.7 ± 0.3% (P<0.05).
No serious adverse effects were seen by the combination drug.
Subanalysis for the patients with considerable reductions of TC demonstrated that the combination drug decreased proteinuria and high sensitive CRP (P<0.05 for both).
Conclusion.
Our data indicate that proteinuria constitutes a determinant of a reduced FMD.
The present results implicate that combination drug is useful to improve adherence and suggest that atorvastatin refines endothelium function as well as lipid profiles in CKD patients.
نمط استشهاد جمعية علماء النفس الأمريكية (APA)
Takenaka, Tsuneo& Takane, Hiroshi& Kikuta, Tomohiro& Watanabe, Yusuke& Suzuki, Hiromichi. 2013. Statin Improves Flow-Mediated Vasodilation in Chronic Kidney Diseases. International Journal of Hypertension،Vol. 2013, no. 2013, pp.1-9.
https://search.emarefa.net/detail/BIM-505520
نمط استشهاد الجمعية الأمريكية للغات الحديثة (MLA)
Takenaka, Tsuneo…[et al.]. Statin Improves Flow-Mediated Vasodilation in Chronic Kidney Diseases. International Journal of Hypertension No. 2013 (2013), pp.1-9.
https://search.emarefa.net/detail/BIM-505520
نمط استشهاد الجمعية الطبية الأمريكية (AMA)
Takenaka, Tsuneo& Takane, Hiroshi& Kikuta, Tomohiro& Watanabe, Yusuke& Suzuki, Hiromichi. Statin Improves Flow-Mediated Vasodilation in Chronic Kidney Diseases. International Journal of Hypertension. 2013. Vol. 2013, no. 2013, pp.1-9.
https://search.emarefa.net/detail/BIM-505520
نوع البيانات
مقالات
لغة النص
الإنجليزية
الملاحظات
Includes bibliographical references
رقم السجل
BIM-505520
قاعدة معامل التأثير والاستشهادات المرجعية العربي "ارسيف Arcif"
أضخم قاعدة بيانات عربية للاستشهادات المرجعية للمجلات العلمية المحكمة الصادرة في العالم العربي
![](/images/ebook-kashef.png)
تقوم هذه الخدمة بالتحقق من التشابه أو الانتحال في الأبحاث والمقالات العلمية والأطروحات الجامعية والكتب والأبحاث باللغة العربية، وتحديد درجة التشابه أو أصالة الأعمال البحثية وحماية ملكيتها الفكرية. تعرف اكثر
![](/images/kashef-image.png)